loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 6f746bcd B121 447a 9f5d C9391e886159 Applno 204168 Form Capsule Extended Release Oral Dosage Eq 20mg Base - Drug Product Composition: Levomilnacipran HCl

    Menu

    Levomilnacipran HCl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 204168 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 20MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LEVOMILNACIPRAN HYDROCHLORIDE(UNII: 371U2ZK31U)
    (levomilnacipran - UNII:UGM0326TXX)     		levomilnacipran40mg

    Inactive Ingredients

    Ingredient Name
    Avera McKennan Hospital
    ethylcelluloses(7Z8S9VYZ4B)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    FERROSOFERRIC OXIDE(XM0M87F357)
    hypromelloses(3NXW29V3WO)
    povidone(FZ989GH94E)
    shellac(46N107B71O)
    SUCROSE(C151H8M554)
    talc(7SEV7J4R1U)
    titanium dioxide(15FIX9V2JP)
    triethyl citrate(8Z96QXD6UM)